Related Experiment Video
Updated: Sep 13, 2025
08:00
Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
6.2K
Targeting Cdc42: Novel Approaches in Cardiovascular Disorders
Rupali Chauhan1, Sushma Devi1, Thakur Gurjeet Singh1
1Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Current Protein & Peptide Science
|July 31, 2025
Summary
Cell division control protein 42 homolog (Cdc42) is a key regulator in cardiovascular health, influencing functions from blood vessel integrity to cardiac development. Targeting Cdc42 shows promise for novel cardiovascular disease treatments and early detection.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Cardiovascular diseases (CVDs) are a major global health burden, necessitating new diagnostic and therapeutic molecular targets.
- Emerging targets for CVDs include cell division control protein 42 homolog (Cdc42), a Rho family GTPase crucial for cardiovascular physiology and pathology.
Purpose of the Study:
- This review elucidates the diverse roles of Cdc42 in cardiovascular complications.
- It highlights Cdc42's significance in endothelial function, vascular smooth muscle regulation, cardiac development, inflammation, and lipid metabolism.
Main Methods:
- This is a review article, synthesizing existing research on Cdc42's function in the cardiovascular system.
- It analyzes data on Cdc42's involvement in signalling pathways, including those affecting lipid metabolism and insulin sensitivity.
Main Results:
- Cdc42 plays a critical role in maintaining endothelial barrier integrity and regulating vascular smooth muscle cell phenotype.
- It is involved in cardiac development, immune response modulation, and influences lipid transport and insulin signaling.
- Cdc42 demonstrates potential as an early biomarker for CVD detection and a therapeutic target.
Conclusions:
- Cdc42 is a multifaceted regulator of cardiovascular processes, offering potential for innovative CVD prevention and treatment strategies.
- Challenges in targeting Cdc42 due to its widespread presence require further research into tissue-specific modulation and downstream effectors.
Related Concept Videos
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
259
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
259
02:15M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
01:30Coronary Artery Disease I: Introduction
58
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
58